ISD Drug Discovery

Our client is a major international pharmaceutical company engaged in research and development across a broad range of human medical disorders, including mental illness, neurological disorders, cancer, and other diseases. (For more details on previous machine learning initiatives, see the earlier case study: Machine Learning for Biochemistry.)

The pharmaceutical industry faces the constant need to accelerate drug discovery while minimizing costs and risks. Key challenges include:

• Identifying promising molecules for synthesis in a resource-efficient manner.
• Enabling data scientists to train and evaluate predictive models quickly, without deep technical overhead.
• Ensuring data security and confidentiality when using shared LLM/model APIs.
• Aggregating vast and heterogeneous biochemical data into a usable, unified format.
• Efficiently searching molecular databases to find relevant compounds based on structure and similarity.

To address these challenges, we developed a state-of-the-art AI-powered platform combining active learning, automation, and secure collaboration:

1. Active Learning for Chemists — Assists chemists in selecting potentially useful molecules for synthesis in iterative learning rounds.
2. Automated Model Training — Provides a user-friendly GUI allowing data scientists to train and tune ML/AI models with just a few clicks.
3. Secure MCP Agents — Facilitates communication with analysts and LLM-powered assistants while preventing sensitive customer data from leaking through public APIs.
4. Integrated Databases — Maintains secure, aggregated data from multiple sources, enabling richer and more informed analysis.
5. Advanced Molecular Search Engines — Supports high-performance searches across massive molecular graphs by substructure and similarity.

• Accelerated molecule selection and AI model training, significantly reducing time-to-insight.
• Simplified workflow for chemists and data scientists through intelligent automation and AI-assisted workflows, enabling focus on higher-value decisions.

• Ensured strong data privacy and regulatory compliance through secure MCP communication agents.

• Unified access to diverse datasets, improving model accuracy and prediction reliability.

• Enabled high-throughput search of molecular structures, supporting faster and smarter AI-driven drug discovery.